X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB VENUS REMEDIES UNICHEM LAB/
VENUS REMEDIES
 
P/E (TTM) x 23.6 -534.9 - View Chart
P/BV x 2.2 0.2 1,471.1% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 UNICHEM LAB   VENUS REMEDIES
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
VENUS REMEDIES
Mar-17
UNICHEM LAB/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs320143 224.0%   
Low Rs22165 340.0%   
Sales per share (Unadj.) Rs167.2324.2 51.6%  
Earnings per share (Unadj.) Rs12.06.4 186.6%  
Cash flow per share (Unadj.) Rs16.940.6 41.7%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs117.0366.0 32.0%  
Shares outstanding (eoy) m90.8812.34 736.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.60.3 504.7%   
Avg P/E ratio x22.616.2 139.5%  
P/CF ratio (eoy) x16.02.6 623.8%  
Price / Book Value ratio x2.30.3 813.9%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m24,5781,282 1,917.0%   
No. of employees `0005.20.9 574.6%   
Total wages/salary Rs m2,487251 991.0%   
Avg. sales/employee Rs Th2,928.34,430.1 66.1%   
Avg. wages/employee Rs Th479.4278.0 172.5%   
Avg. net profit/employee Rs Th209.487.6 239.1%   
INCOME DATA
Net Sales Rs m15,1954,000 379.8%  
Other income Rs m11023 485.5%   
Total revenues Rs m15,3054,023 380.4%   
Gross profit Rs m1,788785 227.8%  
Depreciation Rs m452422 107.2%   
Interest Rs m34344 9.8%   
Profit before tax Rs m1,41342 3,355.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m326-37 -880.5%   
Profit after tax Rs m1,08779 1,374.0%  
Gross profit margin %11.819.6 60.0%  
Effective tax rate %23.1-87.9 -26.2%   
Net profit margin %7.22.0 361.7%  
BALANCE SHEET DATA
Current assets Rs m6,4262,606 246.6%   
Current liabilities Rs m3,9171,980 197.8%   
Net working cap to sales %16.515.6 105.5%  
Current ratio x1.61.3 124.6%  
Inventory Days Days68128 52.7%  
Debtors Days Days7743 178.4%  
Net fixed assets Rs m7,4105,353 138.4%   
Share capital Rs m182123 147.3%   
"Free" reserves Rs m10,4544,393 238.0%   
Net worth Rs m10,6364,516 235.5%   
Long term debt Rs m41,618 0.3%   
Total assets Rs m15,2588,291 184.0%  
Interest coverage x42.91.1 3,823.4%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x1.00.5 206.4%   
Return on assets %7.35.1 144.0%  
Return on equity %10.21.8 583.4%  
Return on capital %13.66.3 216.1%  
Exports to sales %24.10-   
Imports to sales %4.918.4 26.9%   
Exports (fob) Rs m3,666NA-   
Imports (cif) Rs m752736 102.1%   
Fx inflow Rs m5,2980-   
Fx outflow Rs m0736 0.0%   
Net fx Rs m5,298-736 -719.6%   
CASH FLOW
From Operations Rs m683997 68.5%  
From Investments Rs m-1,316-461 285.2%  
From Financial Activity Rs m592-571 -103.7%  
Net Cashflow Rs m-40-35 113.7%  

Share Holding

Indian Promoters % 50.1 32.9 152.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.2 8,388.9%  
FIIs % 3.0 0.6 517.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 66.4 47.7%  
Shareholders   20,176 20,121 100.3%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   PANACEA BIOTECH  DISHMAN PHARMA  J.B.CHEMICALS  NATCO PHARMA  DIVIS LABORATORIES  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 300 Points; Capital Goods Stocks Down 3%(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a negative note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


May 18, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS